OPKO Health Total Liabilities 2010-2024 | OPK

OPKO Health total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
OPKO Health Annual Total Liabilities
(Millions of US $)
2023 $622
2022 $606
2021 $715
2020 $802
2019 $695
2018 $660
2017 $746
2016 $675
2015 $819
2014 $432
2013 $519
2012 $111
2011 $69
2010 $55
2009 $56
OPKO Health Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $721
2023-12-31 $622
2023-09-30 $612
2023-06-30 $624
2023-03-31 $618
2022-12-31 $606
2022-09-30 $596
2022-06-30 $651
2022-03-31 $692
2021-12-31 $715
2021-09-30 $652
2021-06-30 $679
2021-03-31 $823
2020-12-31 $802
2020-09-30 $748
2020-06-30 $735
2020-03-31 $684
2019-12-31 $695
2019-09-30 $728
2019-06-30 $747
2019-03-31 $813
2018-12-31 $660
2018-09-30 $692
2018-06-30 $720
2018-03-31 $756
2017-12-31 $746
2017-09-30 $633
2017-06-30 $662
2017-03-31 $653
2016-12-31 $675
2016-09-30 $695
2016-06-30 $758
2016-03-31 $795
2015-12-31 $819
2015-09-30 $1,046
2015-06-30 $699
2015-03-31 $700
2014-12-31 $432
2014-09-30 $408
2014-06-30 $414
2014-03-31 $524
2013-12-31 $519
2013-09-30 $515
2013-06-30 $329
2013-03-31 $334
2012-12-31 $111
2012-09-30 $104
2012-06-30 $79
2012-03-31 $77
2011-12-31 $69
2011-09-30 $49
2011-06-30 $49
2011-03-31 $53
2010-12-31 $55
2010-09-30 $48
2010-06-30 $18
2010-03-31 $31
2009-12-31 $56
2009-09-30 $19
2009-06-30 $21
2009-03-31 $27
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.032B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $231.755B 27.80
Intuitive Surgical (ISRG) United States $156.818B 88.79
Alcon (ALC) Switzerland $46.054B 32.99
IQVIA Holdings (IQV) United States $43.692B 24.76
IDEXX Laboratories (IDXX) United States $38.792B 45.47
Edwards Lifesciences (EW) United States $37.584B 24.08
DexCom (DXCM) United States $25.452B 36.57
STERIS (STE) Ireland $23.012B 26.88
Waters (WAT) United States $18.861B 27.72
Hologic (HOLX) United States $18.350B 20.53
SONOVA HOLDING (SONVY) Switzerland $18.023B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $11.907B 13.90
Teleflex (TFX) United States $10.377B 16.15
Sysmex ADR (SSMXY) Japan $10.032B 31.46
Globus Medical (GMED) United States $9.732B 28.53
Penumbra (PEN) United States $6.917B 78.60
Glaukos (GKOS) United States $6.035B 0.00
Masimo (MASI) United States $5.796B 33.33
TransMedics (TMDX) United States $4.627B 439.03
Integer Holdings (ITGR) United States $3.914B 22.90
PROCEPT BioRobotics (PRCT) United States $3.182B 0.00
Inari Medical (NARI) United States $3.130B 0.00
LivaNova (LIVN) United Kingdom $2.903B 17.24
Tandem Diabetes Care (TNDM) United States $2.587B 0.00
Integra LifeSciences Holdings (IART) United States $2.477B 10.80
Veracyte (VCYT) United States $1.813B 0.00
RxSight (RXST) United States $1.646B 0.00
Alphatec Holdings (ATEC) United States $1.526B 0.00
Artivion (AORT) United States $1.146B 109.92
Silk Road Medical (SILK) United States $1.066B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.062B 20.66
Pulse Biosciences (PLSE) United States $1.045B 0.00
OrthoPediatrics (KIDS) United States $0.777B 0.00
Paragon 28 (FNA) United States $0.715B 0.00
SiBone (SIBN) United States $0.666B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.620B 0.00
IRadimed (IRMD) United States $0.602B 33.70
Mesa Laboratories (MLAB) United States $0.595B 17.60
Pacific Biosciences Of California (PACB) United States $0.581B 0.00
Treace Medical Concepts (TMCI) United States $0.479B 0.00
AxoGen (AXGN) United States $0.404B 0.00
Sight Sciences (SGHT) United States $0.386B 0.00
Nevro (NVRO) United States $0.358B 0.00
AngioDynamics (ANGO) United States $0.306B 0.00
Tactile Systems Technology (TCMD) United States $0.301B 10.31
Delcath Systems (DCTH) United States $0.242B 0.00
Semler Scientific (SMLR) United States $0.236B 11.96
NeuroPace (NPCE) United States $0.229B 0.00
Inogen (INGN) United States $0.228B 0.00
CVRx (CVRX) United States $0.208B 0.00
ClearPoint Neuro (CLPT) United States $0.203B 0.00
908 Devices (MASS) United States $0.200B 0.00
Accuray (ARAY) United States $0.191B 0.00
Atossa Genetics (ATOS) United States $0.185B 0.00
EDAP TMS S.A (EDAP) France $0.173B 0.00
Alpha Tau Medical (DRTS) Israel $0.148B 0.00
KORU Medical Systems (KRMD) United States $0.113B 0.00
Spectral Diagnostics (EDTXF) Canada $0.103B 0.00
Sensus Healthcare (SRTS) United States $0.103B 21.62
T2 Biosystems (TTOO) United States $0.089B 0.00
InspireMD (NSPR) Israel $0.085B 0.00
Hyperfine (HYPR) United States $0.083B 0.00
Monogram Orthopaedics (MGRM) United States $0.081B 0.00
EnVVeno Medical (NVNO) United States $0.077B 0.00
LENSAR (LNSR) United States $0.062B 0.00
Neuronetics (STIM) United States $0.057B 0.00
Vaso (VASO) United States $0.050B 13.49
Vicarious Surgical (RBOT) United States $0.046B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.042B 0.00
Precision Optics (POCI) United States $0.039B 0.00
DarioHealth (DRIO) United States $0.036B 0.00
ReWalk Robotics (LFWD) Israel $0.036B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
Rapid Micro Biosystems (RPID) United States $0.029B 0.00
Accelerate Diagnostics (AXDX) United States $0.029B 0.00
Autonomix Medical (AMIX) United States $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
Aspira Women's Health (AWH) United States $0.021B 0.00
NexGel (NXGL) United States $0.020B 0.00
Pixie Dust Technologies (PXDT) Japan $0.019B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
PAVmed (PAVM) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Bluejay Diagnostics (BJDX) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00